Literature DB >> 16462826

The investigational new drug application--who benefits?

Emil J Freireich1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16462826     DOI: 10.1038/ncponc0429

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


× No keyword cloud information.
  1 in total

1.  Should terminally ill patients have the right to take drugs that pass phase I testing? Yes.

Authors:  Emil J Freireich
Journal:  BMJ       Date:  2007-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.